Arizona Spent $582M on Addiction Treatment Last Year. It Also Lost $2.8B to Fraud and Turned Away 140,000 Patients.

On April 28, 2026, AHCCCS published its SFY2025 Annual Substance Use Treatment Report. Arizona’s Medicaid program spent $582 million on substance use disorder treatment services in the state fiscal year ending June 2025. The state covers all three FDA-approved medications for opioid use disorder. By the numbers, Arizona’s investment in addiction treatment is real and substantial.

The same system, over roughly the same period, presided over $2.8 billion in Medicaid billing fraud and the disenrollment of 140,000 patients from the program.

The fraud ran primarily through behavioral health providers, including several with ties to tribal lands that are now under FBI investigation. The Arizona Senate Health and Human Services Committee, under Chair Senator Carine Werner (R-LD4), has held five oversight hearings since July 2025. Werner, who has introduced SB 1611 and SB 1233 targeting fraud accountability and access reform, has been public about what the hearings have shown: patients in the American Indian Health Program, specifically, are being denied addiction and behavioral health care despite providers having the capacity to see them.

The mechanism is reimbursement failure. Providers in the American Indian Health Program can’t get paid reliably under the current AHCCCS billing structure, so they stop scheduling new patients. The patients who most need care — particularly people in rural and tribal communities where the behavioral health provider network is thinnest — are the ones who show up and get told there’s no appointment.

This matters beyond Arizona because it illustrates a consistent pattern in state Medicaid systems: the money allocated for addiction treatment and the money that actually reaches patients in treatment are not the same number, and the gap between them is often widest for populations that already face the most barriers. Werner’s reform package is aimed at closing that gap through enhanced audit requirements, reimbursement reform, and licensing oversight. Whether the bills pass in their current form, and whether they reach patients like the ones who’ve been turned away from the American Indian Health Program, is the question the legislature is now answering.

Rize’s Arizona Watch coverage tracks access and system issues in state-specific detail. Arizona is one of the states where the treatment infrastructure, on paper, looks capable of serving the need. The SFY2025 data shows a system where that capability isn’t always reaching the people who need it — and where the gap between investment and access is still being reckoned with.